- Q3 2022 Nabriva Therapeutics PLC Earnings Call TranscriptNov 10, 2022$2.18 (+3.32%)Earnings
- Q2 2022 Nabriva Therapeutics PLC Earnings Call TranscriptAug 03, 2022$4.93 (+8.72%)Earnings
- Q1 2022 Nabriva Therapeutics PLC Earnings Call TranscriptMay 05, 2022$7.25 (-5.01%)Earnings
- Q4 2021 Nabriva Therapeutics PLC Earnings Call TranscriptMar 29, 2022$12.34 (+4.38%)Earnings
- Q3 2021 Nabriva Therapeutics PLC Earnings Call TranscriptNov 09, 2021$33.5 (+3.08%)Earnings
- Q2 2021 Nabriva Therapeutics PLC Earnings Call TranscriptAug 05, 2021$29 (-4.13%)Earnings
- Q1 2021 Nabriva Therapeutics PLC Earnings Call TranscriptMay 06, 2021$37.25 (-6.88%)Earnings
- Q4 2020 Nabriva Therapeutics PLC Earnings Call TranscriptMar 11, 2021$45.75 (+4.57%)Earnings
- Q3 2020 Nabriva Therapeutics PLC Earnings Call TranscriptNov 05, 2020$122.05 (+3.87%)Earnings
- Q2 2020 Nabriva Therapeutics PLC Earnings Call TranscriptAug 06, 2020$202.5 (-1.89%)Earnings
- Nabriva Therapeutics PLC at Bank of America Merrill Lynch Healthcare Conference (Virtual) TranscriptMay 13, 2020
- Q1 2020 Nabriva Therapeutics PLC Earnings Call TranscriptMay 11, 2020$182.5 (+19.77%)Earnings
- Q4 2019 Nabriva Therapeutics PLC Earnings Call TranscriptMar 12, 2020$255 (-15.70%)Earnings
- Q3 2019 Nabriva Therapeutics PLC Earnings Call TranscriptNov 12, 2019$495 (-1.00%)Earnings
- Nabriva Therapeutics PLC at Morgan Stanley Healthcare Conference TranscriptSep 09, 2019
- Nabriva Therapeutics plc - Special Call TranscriptAug 19, 2019
- Nabriva Therapeutics PLC at Bank of America Merrill Lynch Health Care Conference TranscriptMay 15, 2019
- Nabriva Therapeutics plc Complete Response Letter from FDA on NDA Conference Call TranscriptMay 01, 2019
Q4 2020 Nabriva Therapeutics PLC Earnings Call Transcript
Ladies and gentlemen, thank you for standing by, and welcome to the Nabriva Therapeutics Fourth Quarter 2020 Financial Results Call. (Operator Instructions)
I would now like to hand the conference over to your speaker today, Mr. Gary Sender, Chief Financial Officer. The floor is yours.
Thank you, and good afternoon, everyone. Welcome to Nabriva's conference call and webcast to discuss the fourth quarter and full year 2020 earnings and business updates.
Before we begin, I would like to remind everyone that this conference call and webcast will contain forward-looking statements about the company. These statements are subject to the risks and uncertainties that could cause actual results to differ. Please note that these forward-looking statements reflect our opinions only as of the date of this call. We will undertake no obligation to revise or publicly release the results of any revisions to these forward-looking statements in light of new information or future events.
Factors that
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)